PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib-MedSci.cn

PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib

Ding, X; Zhu, Z; Lapek, J; McMillan, EA; Zhang, A; Chung, CY; Dubbury, S; Lapira, J; Firdaus, S; Kang, XL; Gao, JJ; Oyer, J; Chionis, J; Rollins, RA; Li, LJ; Niessen, S; Bagrodia, S; Zhang, LL; VanArsdale, T

Ding, X; Zhang, LL; VanArsdale, T (通讯作者)，Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA.